TİYENİL-TİYAZOL-ARİL-TİYOÜRE HİBRİT MOLEKÜLLERİN SENTEZİ VE BİYOLOJİK AKTİVİTELERİNİN APOPTOTİK YOL ÜZERİNDEN ANTİ-KANSER ETKİLERİNİN ARAŞTIRILMASI

Yıl 2019, , 87 - 93, 20.09.2019

Şengül Dilem Doğan , Sümeyye Uğur Ayşe Kübra Karaboğa Arslan Ebru Öztürk Ahmet Cumaoğlu , Mükerrem Betül Yerer

https://doi.org/10.34108/eujhs.493005

Cited By: 1

Öz

Tiyenil-tiyazol-aril-tiyoüre
türevleri (4a-4e) amino-4-(2-tiyenil)tiyazol ve fenilizotiyasiyanatların
reaksiyonları sonucu sentezlenmiştir. Sentezlenen bileşikler IR, ¹H-NMR
ve kütle spektrumları ile karekterize edildi. Beş tiyoüre türevinin
anti-proliferatif etkileri A549 (KHDAK) hücrelerinde gerçek zamanlı hücre
analizörü xCELLigence sistemi ile incelendi. Gerçek zamanlı sistemde sitotoksik
olduğu gösterilmiş olan 2 tiyoürenin moleküler etki mekanizmaları,
mitokondriyal membran potansiyeli ΔψM spektrofotometrik olarak, sitokrom c
western blot methoduyla ve Bcl-2 ise qRT-PCR ile araştırılmıştır. 4e
diğerlerinden daha etkili bulunmuştur. 4e
IC₅₀ değerleri 24 ve 48 saat için sırasıyla 29,6 µM ve 22,3 µM
olarak hesaplanmıştır. Bir triflorometil (-CF₃) grubunu içeren 4e
molekülü bir anti-kanserojen madde olarak düşünülebilir ve daha ileri
araştırmalar yapılabilir.0000-0003-1761-188X
 

Anahtar Kelimeler

Tiyoüre, Antikanser activite, Tiyazol, Sentez

Kaynakça

• 1. Auer H, Oehler R, Lindner R, et al. Characterisation of genotoxic properties of 2′, 2′-difluorodeoxycytidine. Mutat Res Genet Toxicol Environ Mutagen, 1997; 393: 165-173.
• 2. Aydemir N and Bilaloğlu R. Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat Res Genet Toxicol Environ Mutagen, 2003; 537: 43-51.
• 3. Chen J-N, Wang X-F, Li T, et al. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents. Eur J Med Chem, 2016; 107: 12-25.
• 4. Kumbhare RM, Kumar KV, Ramaiah MJ, et al. Synthesis and biological evaluation of novel Mannich bases of 2-arylimidazo [2, 1-b] benzothiazoles as potential anti-cancer agents. Eur J Med Chem, 2011; 46: 4258-4266.
• 5. Sadeghian-Rizi S, Khodarahmi GA, Sakhteman A, et al. Biological evaluation, docking and molecular dynamic simulation of some novel diaryl urea derivatives bearing quinoxalindione moiety. Res Pharm Sci, 2017; 12: 500.
• 6. Taleghani A, Nasseri MA, and Iranshahi M. Synthesis of dual-action parthenolide prodrugs as potent anticancer agents. Bioorg Chem, 2017; 71: 128-134.
• 7. Wang M, Xu S, Lei H, et al. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold. Bioorg Med Chem, 2017; 25: 5754-5763.
• 8. Decker M. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond. Curr Med Chem, 2011; 18: 1464-1475.
• 9. Al-Showiman SS, Soliman SM, Ghabbour HA, and AlDamen MA. Synthesis, characterization, X-ray structure, computational studies, and bioassay of novel compounds combining thiophene and benzimidazole or 1, 2, 4-triazole moieties. Chem Cent J, 2017; 11: 51.
• 10. Dos Santos FA, Pereira MC, de Oliveira TB, et al. Anticancer properties of thiophene derivatives in breast cancer MCF-7 cells. Anti-Cancer Drugs, 2018; 29: 157-166.
• 11. Hafez HN, Alsalamah SA, and El-Gazzar A-R. Synthesis of thiophene and N-substituted thieno [3, 2-d] pyrimidine derivatives as potent antitumor and antibacterial agents. Acta Pharm, 2017; 67: 275-292.
• 12. Al-Omair MA, Sayed AR, and Youssef MM. Synthesis and Biological Evaluation of Bisthiazoles and Polythiazoles. Molecules, 2018; 23: 1133.
• 13. Ghorab M and El-Batal A. Synthesis of some new thiazole derivatives. antifungal activity and ultrastructure changes of some mycotoxin producing fungi. Boll Chim Farm, 2002; 141: 110-117.
• 14. Mohareb RM, Abdallah AE, and Ahmed EA. Synthesis and cytotoxicity evaluation of thiazole derivatives obtained from 2-amino-4, 5, 6, 7-tetrahydrobenzo [b] thiophene-3-carbonitrile. Acta Pharm, 2017; 67: 495-510.
• 15. Begum S, Choudhary MI, and Khan KM. Synthesis, phytotoxic, cytotoxic, acetylcholinesterase and butrylcholinesterase activities of N, N′-diaryl unsymmetrically substituted thioureas. Nat Prod Res, 2009; 23: 1719-1730.
• 16. Chen L-J, Bao J, Mei F-M, and Li G-X. Oxidative carbonylation of aniline to N, N′-diphenyl urea catalyzed by cobalt (II)–Schiff base complex/pyridine catalytic system. Catal Commun, 2008; 9: 658-663.
• 17. Jiang N, Bu Y, Wang Y, et al. Design, Synthesis and Structure-Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors. Molecules, 2016; 21: 1572.
• 18. Liu W, Zhou J, Zhang T, et al. Design and synthesis of thiourea derivatives containing a benzo [5, 6] cyclohepta [1, 2-b] pyridine moiety as potential antitumor and anti-inflammatory agents. Bioorg Med Chem Lett, 2012; 22: 2701-2704.
• 19. Özgeriş B, Akbaba Y, Özdemir Ö, et al. Synthesis and Anticancer Activity of Novel Ureas and Sulfamides Incorporating 1-Aminotetralins. Arch Med Res, 2017; 48: 513-519.
• 20. Antúnez D-JB, Greenhalgh MD, Fallan C, et al. Enantioselective synthesis of 2, 3-disubstituted trans-2, 3-dihydrobenzofurans using a Brønsted base/thiourea bifunctional catalyst. Org Biomol Chem, 2016; 14: 7268-7274.
• 21. Chen J, Liu D, Butt N, et al. Palladium‐Catalyzed Asymmetric Hydrogenation of α‐Acyloxy‐1‐arylethanones. Angew Chem Int Ed, 2013; 52: 11632-11636.
• 22. Zhu Y-P, Yuan J-J, Zhao Q, et al. I 2/CuO-catalyzed tandem cyclization strategy for one-pot synthesis of substituted 2-aminothiozole from easily available aromatic ketones/α, β-unsaturated ketones and thiourea. Tetrahedron, 2012; 68: 173-178.
• 23. Hassan M, Watari H, AbuAlmaaty A, et al. Apoptosis and molecular targeting therapy in cancer. BioMed Res Int, 2014; 2014.
• 24. Sinha K, Das J, Pal PB, and Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol, 2013; 87: 1157-1180.
• 25. Czabotar PE, Lessene G, Strasser A, and Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol, 2014; 15: 49.
• 26. Ly JD, Grubb D, and Lawen A. The mitochondrial membrane potential (Δψm) in apoptosis; an update. Apoptosis, 2003; 8: 115-128.
• 27. McConkey DJ, Choi W, Marquis L, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev, 2009; 28: 335-344.
• 28. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 1997; 275: 1129-1132.
• 29. Huang X-C, Wang M, Pan Y-M, et al. Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid. Eur J Med Chem, 2013; 69: 508-520.
• 30. Lv P-C, Li H-Q, Sun J, et al. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg Med Chem Lett, 2010; 18: 4606-4614.
• 31. Madabhushi S, Mallu KKR, Vangipuram VS, et al. Synthesis of novel benzimidazole functionalized chiral thioureas and evaluation of their antibacterial and anticancer activities. Bioorg Med Chem Lett, 2014; 24: 4822-4825.
• 32. Qiao L, Huang J, Hu W, et al. Synthesis, characterization, and in vitro evaluation and in silico molecular docking of thiourea derivatives incorporating 4-(trifluoromethyl) phenyl moiety. J Mol Struct, 2017; 1139: 149-159.
• 33. Tokala R, Bale S, Janrao IP, et al. Synthesis of 1, 2, 4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents. Bioorg Med Chem Lett, 2018; 28: 1919-1924.
• 34. Xing Y, Zhang W, Song J, et al. Anticancer effects of a novel class rosin-derivatives with different mechanisms. Bioorg Med Chem Lett, 2013; 23: 3868-3872.